Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Product Unit Size | Cost | Quantity | Stock |
---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
Purity | ≥98% |
---|---|
Formula | C18H18O4 |
Formula Wt. | 298.33 |
IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
Appearance | White Crystal Powder |
Store Temp | 4°C |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Peptide; NMDA partial agonist.
Polyphenol derivative of caffeic acid found in ...
Endogenous peptide hormone, involved in feeding...
Triterpene saponin found in species of Panax.
Antihistamine with potential neuroprotective ac...
NSAID; COX-1/2 inhibitor.
Tetracycline; protein translation inhibitor, MM...
AhR antagonist.
Paclitaxel derivative
Melanoma-associated antigen.
Found in Cladosporium; PKC inhibitor.
Diterpene found in Taxus; potential microtubule...
Pim-1 inhibitor.
Folate analog; thymidylate synthase inhibitor.<...
Synthetic vitamin E, antioxidant.
Synthetic progestogen; PR agonist.
Organosulfide found in Allium; cholesterol synt...
GSK3 inhibitor.
Impurity of everolimus
α2-adrenergic agonist.